Global Recombinant DNA Technology Market Analysis 2016-2020 and Forecast 2021-2026
Global Recombinant DNA Technology Market Analysis 2016-2020 and Forecast 2021-2026
The Recombinant DNA Technology study provides a comprehensive overview of safety standards, market penetration, and innovation pipelines across major economies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The global Recombinant DNA Technology market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Recombinant DNA Technology by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
by Product
by Types
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Monsanto Company
Roche
Biogen
Amgen
Novartis
Eli Lilly and Company
GenScript
Pfizer Inc.
Novo Nordisk
Sanofi
Merck KGaA
Profacgen
Biocon
GlaxoSmithKline
Cibus
Horizon Discovery Group
New England Biolabs
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Biotechnology and Pharmaceutical Companies
Academic & Government Research Institutes
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
1 Industry Overview
1.1 Recombinant DNA Technology Industry
Figure Recombinant DNA Technology Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Recombinant DNA Technology
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Recombinant DNA Technology
1.2.2 Downstream
Table Application Segment of Recombinant DNA Technology
Table Global Recombinant DNA Technology Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Recombinant DNA Technology Market by Type
3.1 By Type
3.1.1 by Product
Table Major Company List of by Product
3.1.2 by Types
Table Major Company List of by Types
3.2 Market Size
Table Global Recombinant DNA Technology Market 2016-2020, by Type, in USD Million
Figure Global Recombinant DNA Technology Market Growth 2016-2020, by Type, in USD Million
Table Global Recombinant DNA Technology Market 2016-2020, by Type, in Volume
Figure Global Recombinant DNA Technology Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Recombinant DNA Technology Market Forecast 2021-2026, by Type, in USD Million
Table Global Recombinant DNA Technology Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Monsanto Company (Company Profile, Sales Data etc.)
4.1.1 Monsanto Company Profile
Table Monsanto Company Overview List
4.1.2 Monsanto Company Products & Services
4.1.3 Monsanto Company Business Operation Conditions
Table Business Operation of Monsanto Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Roche (Company Profile, Sales Data etc.)
4.2.1 Roche Profile
Table Roche Overview List
4.2.2 Roche Products & Services
4.2.3 Roche Business Operation Conditions
Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Biogen (Company Profile, Sales Data etc.)
4.3.1 Biogen Profile
Table Biogen Overview List
4.3.2 Biogen Products & Services
4.3.3 Biogen Business Operation Conditions
Table Business Operation of Biogen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Amgen (Company Profile, Sales Data etc.)
4.4.1 Amgen Profile
Table Amgen Overview List
4.4.2 Amgen Products & Services
4.4.3 Amgen Business Operation Conditions
Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Novartis (Company Profile, Sales Data etc.)
4.5.1 Novartis Profile
Table Novartis Overview List
4.5.2 Novartis Products & Services
4.5.3 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Eli Lilly and Company (Company Profile, Sales Data etc.)
4.6.1 Eli Lilly and Company Profile
Table Eli Lilly and Company Overview List
4.6.2 Eli Lilly and Company Products & Services
4.6.3 Eli Lilly and Company Business Operation Conditions
Table Business Operation of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 GenScript (Company Profile, Sales Data etc.)
4.7.1 GenScript Profile
Table GenScript Overview List
4.7.2 GenScript Products & Services
4.7.3 GenScript Business Operation Conditions
Table Business Operation of GenScript (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Pfizer Inc. (Company Profile, Sales Data etc.)
4.8.1 Pfizer Inc. Profile
Table Pfizer Inc. Overview List
4.8.2 Pfizer Inc. Products & Services
4.8.3 Pfizer Inc. Business Operation Conditions
Table Business Operation of Pfizer Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Novo Nordisk (Company Profile, Sales Data etc.)
4.9.1 Novo Nordisk Profile
Table Novo Nordisk Overview List
4.9.2 Novo Nordisk Products & Services
4.9.3 Novo Nordisk Business Operation Conditions
Table Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Sanofi (Company Profile, Sales Data etc.)
4.10.1 Sanofi Profile
Table Sanofi Overview List
4.10.2 Sanofi Products & Services
4.10.3 Sanofi Business Operation Conditions
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Merck KGaA (Company Profile, Sales Data etc.)
4.11.1 Merck KGaA Profile
Table Merck KGaA Overview List
4.11.2 Merck KGaA Products & Services
4.11.3 Merck KGaA Business Operation Conditions
Table Business Operation of Merck KGaA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Profacgen (Company Profile, Sales Data etc.)
4.12.1 Profacgen Profile
Table Profacgen Overview List
4.12.2 Profacgen Products & Services
4.12.3 Profacgen Business Operation Conditions
Table Business Operation of Profacgen (Sales Revenue, Cost, Gross Margin)
4.13 Biocon (Company Profile, Sales Data etc.)
4.13.1 Biocon Profile
Table Biocon Overview List
4.13.2 Biocon Products & Services
4.13.3 Biocon Business Operation Conditions
Table Business Operation of Biocon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 GlaxoSmithKline (Company Profile, Sales Data etc.)
4.14.1 GlaxoSmithKline Profile
Table GlaxoSmithKline Overview List
4.14.2 GlaxoSmithKline Products & Services
4.14.3 GlaxoSmithKline Business Operation Conditions
Table Business Operation of GlaxoSmithKline (Sales Revenue, Cost, Gross Margin)
4.15 Cibus (Company Profile, Sales Data etc.)
4.15.1 Cibus Profile
Table Cibus Overview List
4.15.2 Cibus Products & Services
4.15.3 Cibus Business Operation Conditions
Table Business Operation of Cibus (Sales Revenue, Cost, Gross Margin)
4.16 Horizon Discovery Group (Company Profile, Sales Data etc.)
4.16.1 Horizon Discovery Group Profile
Table Horizon Discovery Group Overview List
4.16.2 Horizon Discovery Group Products & Services
4.16.3 Horizon Discovery Group Business Operation Conditions
Table Business Operation of Horizon Discovery Group (Sales Revenue, Cost, Gross Margin)
4.17 New England Biolabs (Company Profile, Sales Data etc.)
4.17.1 New England Biolabs Profile
Table New England Biolabs Overview List
4.17.2 New England Biolabs Products & Services
4.17.3 New England Biolabs Business Operation Conditions
Table Business Operation of New England Biolabs (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Recombinant DNA Technology Sales Revenue 2016-2020, by Company, in USD Million
Table Global Recombinant DNA Technology Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Recombinant DNA Technology Sales Revenue Share in 2020, by Company, in USD Million
Table Global Recombinant DNA Technology Sales Volume 2016-2020, by Company, in Volume
Table Global Recombinant DNA Technology Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Recombinant DNA Technology Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Recombinant DNA Technology Market Concentration, in 2020
Figure Europe Recombinant DNA Technology Market Market Concentration, in 2020
Figure Asia-Pacific Recombinant DNA Technology MMarket Concentration, in 2020
Figure South America Recombinant DNA Technology Market Concentration, in 2020
Figure Middle East & Africa Recombinant DNA Technology Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Biotechnology and Pharmaceutical Companies
Figure Recombinant DNA Technology Demand in Biotechnology and Pharmaceutical Companies , 2016-2020, in USD Million
Figure Recombinant DNA Technology Demand in Biotechnology and Pharmaceutical Companies , 2016-2020, in Volume
6.1.2 Demand in Academic & Government Research Institutes
Figure Recombinant DNA Technology Demand in Academic & Government Research Institutes , 2016-2020, in USD Million
Figure Recombinant DNA Technology Demand in Academic & Government Research Institutes , 2016-2020, in Volume
6.1.3 Demand in Others
Figure Recombinant DNA Technology Demand in Others , 2016-2020, in USD Million
Figure Recombinant DNA Technology Demand in Others , 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Recombinant DNA Technology Demand Forecast 2021-2026, by Application, in USD Million
Figure Recombinant DNA Technology Market Growth 2021-2026, by Application, in USD Million
Figure Recombinant DNA Technology Market Share in 2026, by Application, in USD Million
Table Recombinant DNA Technology Demand Forecast 2021-2026, by Application, in Volume
Table Recombinant DNA Technology Market Growth 2021-2026, by Application, in Volume
Table Recombinant DNA Technology Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Recombinant DNA Technology Production 2016-2020, by Region, in USD Million
Table Recombinant DNA Technology Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Recombinant DNA Technology Market 2016-2020, by Region, in USD Million
Table Global Recombinant DNA Technology Market Share 2016-2020, by Region, in USD Million
Table Global Recombinant DNA Technology Market 2016-2020, by Region, in Volume
Table Global Recombinant DNA Technology Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Recombinant DNA Technology Market Size and Growth 2016-2020, in USD Million
Figure North America Recombinant DNA Technology Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Recombinant DNA Technology Market Size 2016-2020, by Country, in USD Million
Table North America Recombinant DNA Technology Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Recombinant DNA Technology Market Size and Growth 2016-2020, in USD Million
Figure Europe Recombinant DNA Technology Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Recombinant DNA Technology Market Size 2016-2020, by Country, in USD Million
Table Europe Recombinant DNA Technology Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Recombinant DNA Technology Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Recombinant DNA Technology Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Recombinant DNA Technology Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Recombinant DNA Technology Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Recombinant DNA Technology Market Size and Growth 2016-2020, in USD Million
Figure South America Recombinant DNA Technology Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Recombinant DNA Technology Market Size 2016-2020, by Country, in USD Million
Table South America Recombinant DNA Technology Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Recombinant DNA Technology Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Recombinant DNA Technology Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Recombinant DNA Technology Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Recombinant DNA Technology Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Recombinant DNA Technology Market Forecast 2021-2026, by Region, in USD Million
Table Recombinant DNA Technology Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
Research Methodology:
Recombinant DNA Technology Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|